| Ytd | -69.79% | |
| 1y | -79.63% |
| Open | 3.65 | Prev Close | 3.87 | Low | 3.62 | High | 3.94 | Mkt Cap | 9.36M |
| Vol | 96.53K | Avg Vol | 116.51K | EPS | -2.30 | P/E | N/A | Forward P/E | -0.52 |
| Beta | 1.43 | Short Ratio | 0.98 | Inst. Own | 11.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-04 | 50-d Avg | 1.29 | 200-d Avg | 1.63 | 1yr Est | 15.75 |
PSTV News
CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("P
Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analys
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
Benzinga examined the prospects for many investors' favorite stocks over the last week — here
US stock futures down, investors focus on Sify, Boot Barn, Wealthfront, Plus Therapeutics, Solowin;
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday'
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announce
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on T
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday.
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session.
